Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Devonian Health Group Inc (GSD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1750 0.0000    0.00%
31/05 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.1600 / 0.2000
  • Day's Range: 0.1750 - 0.1750
Type:  Equity
Market:  Canada
Devonian Health Group 0.1750 0.0000 0.00%

Devonian Health Group Inc Company Profile

 
Get an in-depth profile of Devonian Health Group Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.

Contact Information

Address 360, rue des Entrepreneurs Montmagny
Québec, G5V 4T1
Canada
Phone 514 248 7509
Fax -

Top Executives

Name Age Since Title
Francois Malouin - 2019 Member of Scientific Advisory Board
Louis Flamand - 2017 Member of Scientific Advisory Board & Independent Director
George G. Zhanel - 2019 Member of Scientific Advisory Board
John Trant - 2019 Member of Scientific Advisory Board
Ian D. R. Landells - 2019 Member of Clinical Dermatology Advisory Board
Sam Hanna - 2019 Member of Clinical Dermatology Advisory Board
David C. Baker 60 2023 Independent Non-Executive Chairman
Suha Jabaji - 2019 Member of Scientific Advisory Board
Jerry Tan - 2019 Member of Clinical Dermatology Advisory Board
Jaggi Rao - 2019 Member of Clinical Dermatology Advisory Board
Andre P. Boulet 65 2015 Chief Scientific Officer & Director
Luc D. Gregoire 64 2023 President, CEO & Director
Jean Forcione - 2023 Independent Director
Edouard Dahl - 2023 Independent Director
Kathryn J. Gregory 61 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSD Comments

Write your thoughts about Devonian Health Group Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email